Subscribe to Pharmaceutical Processing Blogs

The Lead

Smart Packaging

April 16, 2014 | by Mike Auerbach, Editor-in Chief | Comments

While smart companies consider the final packaging of their product concurrently with the development of the product, sometimes it’s evident that even the smartest companies fail to consider every aspect of their packaging when it finally comes in contact with the consumer.

View Sample

FREE Daily Email Newsletter

Ranbaxy: Lessons and Opportunities

April 10, 2014 8:48 am | by Girish Malhotra, President, EPCOT International | Comments

Will Sun’s latest acquisition change the global pharma landscape, or result in yet another problem-filled “me too” pharma company?                    


How Will Big Data Affect Manufacturing? Manufacturers Weigh In

April 2, 2014 4:00 pm | by Greg Goodwin, Research Associate, LNS Research | Comments

The current buzz-term “Big Data” may be slightly misleading in the strictest sense. The concept is nothing new. Most manufacturers are quite accustomed to having “big,” some might say huge, amounts of data flowing throughout their organizations, but have historically lacked the context that gives that data actionable meaning—giving birth to the oft used phrase, “data rich, but information poor.”


Dust Off That Tinfoil Hat: Vaccinations

March 21, 2014 5:23 pm | by Nikita Ernst, Associate Editor | Comments

The controversy over vaccinations is back in the spotlight, after a Colorado bill passed tightening the loophole that allows parents to choose not to vaccinate, and actress Kristen Cavalarri spoke out against vaccinations claiming a connection with autism. What's more frightening is the frequency of outbreaks of diseases we thought we'd eradicated. 


What Flu Data Tells Us

February 27, 2014 8:55 am | by Mike Auerbach, Editor in Chief | Comments

In the past I have railed against misinformation on the web and those who use this misinformation to support their beliefs. In particular I have spoken at length about the misinformation concerning vaccinations – that there has been no credible evidence – ever – that vaccination cause any type of permanent maladies or side effects. And yet – people still think vaccines are evil and should be avoided.


The ‘Brand’ Value of Integrity and Product Traceability in the Pharmaceutical Supply Chain

February 20, 2014 8:34 am | by Tom Singer, Principal at Tompkins International | Comments

Serialization and traceability can be powerful tools to combat drug counterfeiting and the pharmaceutical grey market. This is hardly a new concept, and many voices have been raised in their favor. But not all players in the pharmaceutical industry have rushed to implement them.

Will Pharma's Global Customers Redefine Maslow’s Hierarchy of Needs?

January 29, 2014 11:11 am | by Girish Malhotra, President & Founder, Epcot International | Comments

What do Maslow's hierarchy of needs and pharma have in common? On the surface, it might seem they have nothing in common. However, there are many points of connection in today's global economic landscape where the world has not only flattened but also shrunk.

Lethal Numbers

January 22, 2014 3:20 pm | by Mike Auerbach, Editor in Chief | Comments

Recently, I was listening to a radio news broadcast discussing the 50th anniversary of the first salvo in the war against cigarettes and the efforts to reduce deaths from lung cancer. I heard a commentator say that lung cancer is still the most lethal form of cancer in America. I was curious as to why they chose the term “lethal”.


Reading the Tea Leaves: Predictions for Pharma's Future

January 15, 2014 2:46 pm | by Girish Malhotra, President & Founder, Epcot International | Comments

The human race has one significant weakness. We all want to know what the future holds for us, and we want to know now -- hence the popularity of fortune-telling and such "fields" as astrology. In our desire to predict tomorrow, however, we often forget simple cause and effect.


7 Reasons You Should Benchmark Your Manufacturing Performance

January 15, 2014 1:44 pm | by Mike Roberts, Research Associate, LNS Research | Comments

Whether it’s for internal comparisons, or for measuring the effectiveness of your company against close competitors, benchmarking is a vital continuous improvement tool. And although it’s safe to say that the average executive understands the benefits of benchmarking performance, that doesn’t necessarily mean his or her company has ever participated in such an initiative.


Millions? Billions? A Matter of Perspective

January 9, 2014 8:50 am | by Girish Malhotra, President & Founder, Epcot International | Comments

Numbers have different meanings in different contexts or scenarios. In pharmaceuticals, a billion, or billions, in sales would define a blockbuster, while anything less than that would be seen as a marginal success, or even a failure. However, in the generics world, millions represent a sizeable business opportunity.


Can Emerging Pharma's Leadership Move On to the Next Stage?

January 2, 2014 8:20 am | by Girish Malhotra, President & Founder, Epcot International | Comments

This past summer, when news of regulatory noncompliance troubles in the region reached a high point, I asked Indian pharma CEOs in a post on this site whether they had lost their chance to innovate.        

Meet – “That Guy”

December 18, 2013 3:55 pm | by Mike Auerbach, Editor in Chief | Comments

I’m the guy who looks down his nose at every new health trend and scoffs at those who embark on low-carb diets or overindulging on pomegranates or chugging wheat grass juice or slathering their hands with anti-bacterial soap, or downing multi-vitamins and supplements like Halloween candy.


Enough With Anecdotal Evidence

December 11, 2013 3:27 pm | by Mike Auerbach, Editor in Chief | Comments

There’s a great commercial on television in which one person asks another, “Where did you read that?” and the questioned person responds, “On the internet. They can’t put anything on the internet that isn’t true.” That simple exchange typifies what I’m seeing as a growing trend – if you have a point of view, and you need some sort of citation, footnote, or endorsement for your position – just look to the internet and you can find it.


The Nail That Sticks Out Could Change the World: When Culture Stifles Innovation

December 2, 2013 2:30 pm | by Girish Malhotra, President & Founder, Epcot International | Comments

Who are the technical innovators in the US? The image we often have is that of the young Silicon Valley geek or the surfing California biopharma scientist -- sometimes brash and unafraid to challenge authority and champion new and better ideas.


Close But No Cigar

October 18, 2013 3:07 pm | by Mike Auerbach, Editor in Chief | Comments

Biosimilars have received a lot of attention and “buzz” lately. And, as the FDA continues to hold meetings and put out documents for comment as it decides just how to eventually approve and regulate these biopharm generics there is one question that needs to be addressed.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.